Sinil Pharmaceutical Co. Ltd (012790) - Total Liabilities

Latest as of September 2025: ₩18.23 Billion KRW ≈ $12.35 Million USD

Based on the latest financial reports, Sinil Pharmaceutical Co. Ltd (012790) has total liabilities worth ₩18.23 Billion KRW (≈ $12.35 Million USD) as of September 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Explore Sinil Pharmaceutical Co. Ltd (012790) long-term investment share to see how much of total assets are deployed in long-term investments.

Sinil Pharmaceutical Co. Ltd - Total Liabilities Trend (2014–2024)

This chart illustrates how Sinil Pharmaceutical Co. Ltd's total liabilities have evolved over time, based on quarterly financial data. For the complete balance sheet picture, see 012790 total asset value.

Sinil Pharmaceutical Co. Ltd Competitors by Total Liabilities

The table below lists competitors of Sinil Pharmaceutical Co. Ltd ranked by their total liabilities.

Company	Country	Total Liabilities
Brand Engagement Network Inc NASDAQ:BNAI	USA	$9.03 Million
Sun Peak Metals Corp V:PEAK	Canada	CA$445.98K
TSI Co. Ltd. KQ:277880	Korea	₩170.90 Billion
HLV LIMITED NSE:HLVLTD	India	Rs1.71 Billion
Altamira Gold Corp V:ALTA	Canada	CA$653.54K
CBAK ENERGY TECH. NEW F:B6JA	Germany	€388.80 Million
Yura Tech. Co. Ltd KQ:048430	Korea	₩34.46 Billion
MINDs Lab Inc. KQ:377480	Korea	₩30.32 Billion

Liability Composition Analysis (2014–2024)

This chart breaks down Sinil Pharmaceutical Co. Ltd's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. See Sinil Pharmaceutical Co. Ltd balance sheet quality to measure how much of total assets are equity-financed.

Liquidity & Leverage Metrics

Key Metrics Explained

Metric	Value	Description
Current Ratio	5.63	Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio	N/A	More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio	N/A	Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity	0.12	Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets	0.11	Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how Sinil Pharmaceutical Co. Ltd's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for Sinil Pharmaceutical Co. Ltd (2014–2024)

The table below shows the annual total liabilities of Sinil Pharmaceutical Co. Ltd from 2014 to 2024.

Year	Total Liabilities	Change
2024-12-31	₩19.36 Billion ≈ $13.12 Million	+10.20%
2023-12-31	₩17.56 Billion ≈ $11.90 Million	-10.18%
2022-12-31	₩19.55 Billion ≈ $13.25 Million	+23.94%
2021-12-31	₩15.78 Billion ≈ $10.69 Million	-8.94%
2020-12-31	₩17.33 Billion ≈ $11.74 Million	+4.42%
2019-12-31	₩16.59 Billion ≈ $11.24 Million	+47.90%
2018-12-31	₩11.22 Billion ≈ $7.60 Million	-3.20%
2017-12-31	₩11.59 Billion ≈ $7.85 Million	+6.69%
2016-12-31	₩10.86 Billion ≈ $7.36 Million	+19.49%
2015-12-31	₩9.09 Billion ≈ $6.16 Million	+0.39%
2014-12-31	₩9.06 Billion ≈ $6.14 Million	--

About Sinil Pharmaceutical Co. Ltd

KQ:012790 Korea Drug Manufacturers - Specialty & Generic

Market Cap

$47.47 Million

₩70.05 Billion KRW

Market Cap Rank

#22181 Global

#1383 in Korea

Share Price

₩6060.00

Change (1 day)

+1.00%

52-Week Range

₩4900.00 - ₩6480.00

All Time High

₩50717.45